ARCHIVES

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

Obey Raps Reagan Administration For Blocking Report On Formaldehyde Danger

March 27, 1981

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999